All men between the ages of 55 and 69 should have the option of being screened for prostate cancer. That's according to new guidelines from the U.S. Preventative Services Task Force. It's a departure from 2012, when the task force discouraged screening for cancer with the prostate specific antigen (PSA) test. The procedure has a significant problem with false positives, which can lead to more testing, which in turn can cause impaired sexual functioning and incontinence. We'll discuss the new recommendation, which is open for public comment until May 8.
New Guidelines Let Patients Opt In to Controversial Prostate Cancer Screening
(Photo: Getty Images)
Dr. Kirsten Bibbins-Domingo, professor, UCSF School of Medicine; chair, U.S. Preventative Services Task Force
Dr. Mark Litwin, professor of urology and public health, UCLA